These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6174749)

  • 1. [Graunulocyte collection with high molecule HES--granulocyte collection with IBM plasmapheresis equipment].
    Tsukimoto I; Tsuchida M; Kobayashi K
    Rinsho Ketsueki; 1981 Oct; 22(10):1651-7. PubMed ID: 6174749
    [No Abstract]   [Full Text] [Related]  

  • 2. [Granulocyte collection by intermittent flow centrifugation leukapheresis (IFC) and filtration leukapheresis (FL). Effects of high molecular hes and hydrocortisone on donors].
    Suenaga T; Odaka K; Shiobara S; Sachimichi H; Mori T
    Rinsho Ketsueki; 1981 Oct; 22(10):1667-71. PubMed ID: 6174752
    [No Abstract]   [Full Text] [Related]  

  • 3. [Granulocyte collection with high molecule HES (HM 30) into 2 alternative bags].
    Hiraiwa A; Naoe T; Tahara T; Akao Y; Naito K
    Rinsho Ketsueki; 1981 Oct; 22(10):1658-60. PubMed ID: 6174750
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of granulocyte and platelet collection by semicontinuous plasmapheresis equipment (Hemonetics model 30) on blood donors: with special reference to the effects of high molecular hydroxyethyl starch].
    Shimoyama M; Minato K; Kitahara T
    Rinsho Ketsueki; 1981 Oct; 22(10):1661-6. PubMed ID: 6174751
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydroxyethyl starch and steroid improved collection of normal granulocytes with continuous flow centrifugation gravity leukapheresis.
    Iacone A; Di Bartolomeo P; Di Girolamo G; Torlontano G
    Haematologica; 1981 Oct; 66(5):645-55. PubMed ID: 6171490
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of high molecular HES on erythrocytes during leukapheresis under Hemonetics PEX].
    Mannoji M; Mori H; Kanzaki A; Hashimoto M; Sugihara H
    Rinsho Ketsueki; 1983 Jul; 24(7):955-9. PubMed ID: 6195367
    [No Abstract]   [Full Text] [Related]  

  • 7. A new method to collect granulocytes using a low dose of hydroxyethyl starch.
    Szymanski IO
    Vox Sang; 1983; 44(2):106-14. PubMed ID: 6187130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of high and low molecular weight hydroxyethyl starch on the cellular composition of granulocyte concentrates].
    Aulmann HM; Schnurer U; Müller R; Stangel W; Schumacher S
    Beitr Infusionsther; 1988; 21():127-9. PubMed ID: 2462958
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on low-dose hydroxyethyl starch leukapheresis. Rate of elimination of HES in vivo and function of the harvested granulocytes in vitro.
    Szymanski IO; Teno RA; Gandhi JG; Newburger PE
    Vox Sang; 1984; 47(5):325-9. PubMed ID: 6209854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter trial to document the efficacy and safety of a rapidly excreted analog of hydroxyethyl starch for leukapheresis with a note on steroid stimulation of granulocyte donors.
    Strauss RG; Hester JP; Vogler WR; Higby DJ; Snikeris AC; Imig KM; Greazel C; Mallard G; Burnett D; Gupta S
    Transfusion; 1986; 26(3):258-64. PubMed ID: 2422795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collection and transfusion of granulocytes from stimulated donors.
    Vogler WR; Lawson DH; Moffitt S; Mallard HE; Winton EF
    Prog Clin Biol Res; 1981; 65():29-40. PubMed ID: 7330071
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of hydroxyethyl starch to improve granulocyte collection in the Latham blood processor.
    Huestis DW; White RF; Price MJ; Inman M
    Transfusion; 1975; 15(6):559-64. PubMed ID: 53922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternate dosage regimens for high molecular weight hydroxyethyl starch.
    Rock G; McCombie N
    J Clin Apher; 1985; 2(4):375-7. PubMed ID: 2415507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyethyl starch and granulocyte transfusions: considerations of utility and toxicity profile for patients and donors.
    Ambruso DR
    Transfusion; 2015 Apr; 55(4):911-8. PubMed ID: 25315227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocytapheresis with modified fluid gelatin versus high-molecular-weight hydroxyethyl starch: a matched-pair analysis.
    Dullinger K; Pamler I; Brosig A; Mohrez M; Hähnel V; Offner R; Dormann F; Becke C; Holler E; Ahrens N
    Transfusion; 2017 Feb; 57(2):397-403. PubMed ID: 27859322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled comparison of the efficacy of hetastarch and pentastarch in granulocyte collections by centrifugal leukapheresis.
    Lee JH; Leitman SF; Klein HG
    Blood; 1995 Dec; 86(12):4662-6. PubMed ID: 8541559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of leukocyte and platelet administration in cancer therapy.
    Walker EM; Cannon A; Mitchum EN
    Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukapheresis and granulocyte transfusion.
    Huestis DW
    Haematologia (Budap); 1982; 15(1):39-55. PubMed ID: 7117942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the colloidal plasma substitute 6% HES 40/0,5].
    von Bormann B; Hempelmann G
    Anaesthesist; 1985 May; 34(5):265-6. PubMed ID: 2411161
    [No Abstract]   [Full Text] [Related]  

  • 20. Alternate dosage regimens for high-molecular-weight hydroxyethyl starch.
    Rock G; McCombie N
    Transfusion; 1985; 25(5):417-9. PubMed ID: 2413591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.